Baack Kukreja Janet, Kamat Ashish M
University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit #1373, Houston, TX 77030-4000, USA.
University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit #1373, Houston, TX 77030-4000, USA
Ther Adv Urol. 2017 Apr 11;9(5):111-119. doi: 10.1177/1756287217701699. eCollection 2017 Oct.
Readmissions after major surgical procedures are prevalent across multiple disciplines. Specifically, in urology, with incorporation of early discharge and recovery pathways, readmissions are emerging as an important problem and effecting an epidemic proportion of urology patients. As expected, readmissions have garnered the attention of major healthcare payers in the United States who see readmissions as easy targets because of the association with astronomical costs. More importantly, readmissions have a significant negative impact on patient sense of wellbeing, and places economic and other hardships on the doors of our patients and their families. Here, we explore the reasons patients are readmitted, using radical cystectomy as a case study, and means to decrease the incidence of readmissions. Since time to readmission for most major urologic oncology surgeries is within the first 2 weeks after discharge, this time frame is critical for efforts to improve symptom identification and reduce the total number and severity of readmissions. Readmission reduction to zero is unlikely for any major surgery, but with effective coordinated strategies, we must strive to reduce the rates as much as possible, as a means to improve the care continuum for our patients.
大型外科手术后的再入院情况在多个学科中都很普遍。具体而言,在泌尿外科,随着早期出院和康复路径的引入,再入院正成为一个重要问题,并影响着相当比例的泌尿外科患者。不出所料,再入院问题已引起美国主要医疗保健支付方的关注,他们认为再入院是容易解决的目标,因为其与高昂的费用相关联。更重要的是,再入院对患者的幸福感有重大负面影响,并给我们的患者及其家庭带来经济和其他困难。在此,我们以根治性膀胱切除术为例,探讨患者再入院的原因以及降低再入院发生率的方法。由于大多数主要泌尿外科肿瘤手术的再入院时间在出院后的头两周内,这个时间段对于改善症状识别以及减少再入院的总数和严重程度的努力至关重要。对于任何大型手术来说,将再入院率降至零不太可能,但通过有效的协调策略,我们必须努力尽可能降低再入院率,以此作为改善患者护理连续性的一种手段。